An epidemiological study of the association of coffee with chronic liver disease

Scottish Medical Journal

Volumn 58, Issue 4, 2013, Pages 217-222

  Walton, H B ^a   Masterton, G S ^b   Hayes, P C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Alcohol related liver disease; Cirrhosis; Non alcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALKALINE PHOSPHATASE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; BILIARY CIRRHOSIS; CHILD PUGH SCORE; CHRONIC LIVER DISEASE; COFFEE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DRINKING BEHAVIOR; FEMALE; HUMAN; LIFESTYLE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MULTIVARIATE ANALYSIS; QUESTIONNAIRE; SCORING SYSTEM;

ALCOHOL-RELATED LIVER DISEASE; CIRRHOSIS; NON-ALCOHOLIC FATTY LIVER DISEASE;

CAFFEINE; CASE-CONTROL STUDIES; COFFEE; DITERPENES; END STAGE LIVER DISEASE; FEMALE; HUMANS; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; PROTECTIVE AGENTS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SCOTLAND;

EID: 84901375658     PISSN: 00369330     EISSN: 20456441     Source Type: Journal    
DOI: 10.1177/0036933013507869     Document Type: Article

References (24)

1. Roderick P, Parkes J, Rosenberg W, et al. The epidemiology and health care burden of chronic liver disease. Final report to the British Liver Trust and Foundation for Liver Research: British Liver Trust, 2004, p.12.
2. Health in Scotland 2007: An annual report of the chief medical officer. Scottish Government, 2008, pp.23-27.
3. Information Services Division SMR01, June 2007.
4. Joy D, Thava VR and Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003; 15: 539-543.
5. Pendleton S and Wilson-Webb P. Rising curve: Hepatitis B Infection in the UK. Kent: Hepatitis B Foundation UK, 2007.
6. Health Protection Agency. Hepatitis C in the UK - The Health Protection Agency annual report. UK: Health Protection Agency, 2008.
7. Friberg E, Orsini N, Mantazoros CS, et al. Coffee drinking and risk of endometrial cancer - a population-based cohort study. Int J Cancer 2009; 125: 2413-2417.
8. Shimazu T, Ioue M, Sasazuki S, et al. Coffee consumption and risk of endometrial cancer: a prospective study in Japan. Int J Cancer 2008; 123: 2406-2410.
9. Bidel S, Silventoinen K, Hu G, et al. Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes. Eur J Clin Nutr 2008; 62: 178-185.
10. Tunnicliffe JM and Shearer J. Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 2008; 33: 1290-1300.
11. Mukamal KJ, Hallqvist J, Hammar N, et al. Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program. Am Heart J 2009; 157: 495-501.
12. Klatsky AL, Morton C, Udaltsova N, et al. Coffee, cirrhosis, and transaminase enzymes. Arch Int Med 2006; 166: 1190-1195.
13. Corrao G, Zambon A, Bagnardi V, et al. Coffee, caffeine and the risk of liver cirrhosis. Ann Epidemiol 2001; 11: 458-465.
14. Montella M, Polesel J, La Vecchia C, et al. Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Cancer 2007; 120: 1555-1559.
15. Gelatti U, Covolo L, Franceschini M, et al. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study. J Hepatol 2005; 42: 528-534.
16. Klatsky AL and Armstrong MA. Alcohol, smoking, coffee and cirrhosis. Am J Epidemiol 1992; 136: 1248-1257.
17. Tverdal A and Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol 2003; 13: 419-423.
18. Gallus S, Tavani A, Negri E, et al. Does coffee protect against liver cirrhosis? Ann Epidemiol 2002; 12: 202-205.
19. Tanaka K, Tokunaga S, Kono S, et al. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 1998; 27: 438-443.
20. Arnesen E, Huseby NE, Brenn T, et al. The Tromsø heart study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population. Scan J Clin Lab Invest 1986; 46: 63-70.
21. Casiglia E, Spolaore P, Ginocchio G, et al. Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol 1993; 9: 293-297.
22. Costentin CE, Roudot-Thoraval F, Zafrani ES, et al. Association of caffeine intake and histological features of chronic hepatitis C. J Hepatol 2011; 54: 1123-1129.
23. Cavin C, Holzhaeuser D, Scharf G, et al. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 2002; 40: 1155-1163.
24. Urgert R, Essed N, van der Weg G, et al. Separate effects of the coffee diterpenes cafestol and kahweol on serum lipids and liver aminotransferases. Am J Clin Nutr 1997; 65: 519-524.